Sector Guided Therapeutics, Inc.

Aandelen

GTHP

US40171F5017

Geavanceerde medische apparatuur & technologie

Beurs gesloten - 18:29:09 30-10-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,1500 USD +3,67% Intraday-grafiek van Guided Therapeutics, Inc. +3,45% -72,22%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
+3,67%+3,45%-39,49%-50,00%-72,22%-44,44%-4,31%-73,68%-99,98% 14,48 mln.
-1,72%+3,44%+3,25%+20,85%+20,29%+25,31%+60,56%+10,10%+373,47% 258 mld.
-2,00%+0,75%+4,82%+18,38%+1,45%+7,99%+25,46%-25,51%+197,01% 163 mld.
-3,73%-4,48%+6,24%+22,39%-23,72%-18,49%+67,13%+19,63%+483,32% 150 mld.
-1,66%-8,12%-3,83%-8,74%-55,97%-58,26%-16,12%-2,67%+90,04% 60,84 mld.
-2,57%+3,30%+6,59%+5,86%+7,93%+10,22%+47,55%-23,21%+187,05% 53,03 mld.
0,00%+2,46%+12,96%+15,30%-4,52%-11,97%-6,29%-25,36% - 53,31 mld.
-3,47%+1,04%+1,49%+26,07%+28,51%+21,98%+72,85%+11,04%+304,60% 49,3 mld.
+0,84%-3,12%+9,64%+55,27%+40,20%+9,80%+64,47%-1,28%+726,41% 50,67 mld.
-3,61%+1,99%+5,31%+21,67%+21,82%+34,94%+95,49%+25,89%+230,96% 45,46 mld.
-18,64%-12,41%-13,77%+15,07%+79,93%+138,35%+118,77%-43,14%+70,23% 35,63 mld.
-9,05%-9,06%+4,00%+10,25%-4,54%-8,85%+67,29%-12,54%+281,01% 32,34 mld.
+0,20%+7,17%+17,13%+9,48%-6,64%+2,09%+21,21% - - 34,62 mld.
+1,54%+2,51%+12,66%+12,46%-4,57%-16,12%-35,80%-51,67% - 33,09 mld.
-0,16%+0,66%+12,12%+5,94%+4,30%+2,15%+42,74%-35,70%-3,65% 26,45 mld.
-2,24%+3,55%+12,49%+31,32%+18,04%+23,28%+33,98%-47,93%+302,48% 20,09 mld.
-5,30%-1,11%+2,69%+38,28%+62,27%+72,49%+91,28%-11,24%+209,06% 17,52 mld.
-0,45%-1,10%+19,69%+22,09%-11,17%-25,50%+157,85%+268,24%+3.540,07% 14,42 mld.
-0,43%+2,51%+7,11%-1,29%-8,37%-18,46%-4,16% - - 14,12 mld.
-1,53%+1,34%-13,53%-6,22%-12,22%-8,65%-10,60%-29,20%+85,07% 11,75 mld.
Gemiddelde -2,52%-0,63%+3,38%+13,22%+4,04%+6,89%+44,47%-2,68%+436,07% 56,18 mld.
Gewogen gemiddelde per kap. -2,61%-0,30%+5,04%+18,41%+5,86%+8,75%+47,79%-1,81%+355,95%
  1. Beurs
  2. Aandelen
  3. Koers GTHP
  4. Sector Guided Therapeutics, Inc.